Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better COVID Stock: Moderna vs. Novavax


Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) have shaken up the vaccine world over the past year. Moderna became one of the first to launch a coronavirus vaccine. Novavax may soon enter the market with its vaccine candidate. Shares of both companies soared in 2020. Moderna rose 434% and Novavax surged more than 2,700%. But the story isn't over. Gains have continued this year.

Now, you might be wondering, If I want to invest in just one coronavirus player right now, which one of these hot stocks should I choose? Let's take a look at both companies -- and consider your investing style.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments